MSME (Udyam registered) Ministry of MSME
- Category
- Small (2024-25)
- Udyam number
- UDYAM-TN-02-0003922
Eywa Pharma Private Limited - pharma in Chengalpattu, Tamil Nadu, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹95.96 Lakh
▼ 23% YoY
Net loss · FY 2025
₹2.89 Cr
Net margin -301.2%
EBITDA · FY 2025
-₹1.86 Cr
EBITDA margin -193.8%
Authorised capital
₹30 Cr
Registered with MCA
Paid-up capital
₹29.29 Cr
Issued & subscribed
Company age
11 yrs
Est. 2015
Employees · EPFO
24
Provident fund records
Directors on board
2
As per MCA filings
About Eywa Pharma Private Limited
Data last updated:
Eywa Pharma Private Limited is a private limited company based in Chengalpattu, Tamil Nadu, India, a subsidiary of Eywa Pharma Pte. Ltd. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 27 April 2015 and has been in existence for over 11 years.
The company is registered with the Registrar of Companies (ROC), Chennai, under CIN U74900TN2015PTC100269. Its GSTIN is 33AADCE9404E1Z0 (Tamil Nadu). The company holds 2 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹30 Cr and a paid-up capital of ₹29.29 Cr. It is led by directors Sivakumar Jayaraman (Whole-Time Director) and Seshan Srinivasan.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at A5 Third Cross Road Sipcot IT Park, Chengalpattu, Tamil Nadu.
As per the financials filed for FY 2025, the company reported a revenue of ₹95.96 Lakh, a decline of 23% compared to the previous year. For the same year it recorded a net loss of ₹2.89 Cr (net margin -301.2%) and EBITDA of -₹1.86 Cr (EBITDA margin -193.8%). Revenue has declined at a compounded annual rate (CAGR) of 59% over three years and 46% over five years.
The company has about 24 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Eywa Pharma. The company has 2 deals on record (1 rights issue, 1 secondary share transfer); the latest was in November 2016. The company has 12 MSME Form 1 returns on record between 2019 and 2023, listing 706 overdue payments to 52 micro and small suppliers.
Eywa Pharma Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-TN-02-0003922). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website eywapharma.sg.
Company details
CIN U74900TN2015PTC100269
Registration Number 100269
Incorporation Date 27 April 2015
ROC Chennai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Parent Company Eywa Pharma Pte. Ltd
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-TN-02-0003922
Recognitions & Rankings of Eywa Pharma
Contact details
Eywa Pharma Private Limited's registered office is in Chengalpattu, Tamil Nadu. Its website is eywapharma.sg. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressDoor No.5/A5 Third Cross Road Sipcot IT Park, Siruseri, Chengalpattu, Tamil Nadu, India – 603103
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Eywa Pharma Private Limited, buy the company report.
Comprehensive company report
Eywa Pharma Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Eywa Pharma operates one associated brand: Eywa Pharma. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Pharmaceutical drugs for multiple therapeutic areas are manufactured. | eywapharma.sg |
Business activity
The main business activity of Eywa Pharma is professional, scientific and technical. In detail, this covers scientific research and development.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| M | Professional, Scientific and Technical | M5 | Scientific research and development |
To see the full business activity and turnover split of Eywa Pharma Private Limited, buy the company report.
Financials of Eywa Pharma Private Limited
FY 2025 filings availableEywa Pharma Private Limited reported revenue of ₹95.96 Lakh (down 23% YoY) for FY 2025.
Revenue · FY 2025
₹95.96 Lakh ▼ 23%
Net loss · FY 2025
₹2.89 Cr margin -301.2%
EBITDA · FY 2025
-₹1.86 Cr margin -193.8%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▼ 23%
3 years · compounded
▼ 59%
5 years · compounded
▼ 46%
EBITDA CAGR growth
1 year
▲ 67%
3 years · compounded
▼ 43%
5 years · compounded
▼ 19%
Revenue has declined at a compounded annual rate (CAGR) of 46% over five years, including a 23% fall in the latest year. EBITDA rose 67% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹1.86 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹2.89 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -193.8% | ||||
| Net Profit Margin | -301.2% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Eywa Pharma Private Limited, buy the company report.
Board of directors of Eywa Pharma Private Limited
Eywa Pharma has 2 current directors and 5 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sivakumar Jayaraman Also directs: Zista Pharma LLP | Whole-Time Director | 28 Jul 2018 | 8 Years 3 Months | Current |
| Seshan Srinivasan Also directs: Zista Pharma LLP, Yanthra Consultancy Services Private Limited | Director | 30 Apr 2025 | 1 Years 6 Months | Current |
Auditor
Eywa Pharma Private Limited is audited by Sundar Srini & Sridhar for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Sundar Srini & Sridhar | FY 2023 | 004201S |
Shareholding
The shareholding of Eywa Pharma Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Eywa Pharma Private Limited, buy the company report.
Deals & funding
Eywa Pharma Private Limited has 2 deals on record (1 rights issue, 1 secondary share transfer); the latest was in November 2016.
Total deals
2
Rights issue
1
Secondary share transfer
1
Deals on record (2 of 2)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Nov 2016 | Rights issue | ₹19.35 Cr | Investors: Eywa pharma Pte Ltd |
| Mar 2016 | Secondary share transfer | Undisclosed | Buyer: Eywa pharma Pte Ltd Seller: 4 individuals |
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
No court or tribunal cases involving Eywa Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
Eywa Pharma Private Limited has 12 MSME Form 1 returns on record between 2019 and 2023, listing 706 overdue payments to 52 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 52)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| Silver Sky Tours and Travel Private Limited | |||
| an individual supplier | |||
| an individual supplier | |||
| PMK Advisors Private Limited | |||
| an individual supplier |
To see the full MSME payment records of Eywa Pharma Private Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
Employees & EPFO
Eywa Pharma Private Limited has a workforce of 24 employees on its EPFO records as of Apr 05, 2024, across 1 active EPFO establishment.
Employee count
24
Active EPFO establishments
1
Employee growth
-41.46%
GST
Eywa Pharma has 2 GST registrations: 1 active and 1 cancelled or inactive.
Total GSTINs
2
Active
1
Cancelled / inactive
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 33AADCE9404E1Z0 | Tamil Nadu | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Eywa Pharma Private Limited, buy the company report.
Recent activity
Eywa Pharma Private Limited has 7 board changes on record since 2017: 2 appointments and 5 cessations. The latest: Jayakumar Ramamoorthy ceased to be Managing Director on 30 Apr 2025.
AGM
Eywa Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Ceased
Jayakumar Ramamoorthy ceased to be Managing Director.
Appointed
Seshan Srinivasan was appointed as Director.
Filing
Eywa Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Chennai.
Ceased
Subrata Ghosh ceased to be Whole-Time Director.
Ceased
Seshan Srinivasan ceased to be Director.
Appointed
Sivakumar Jayaraman was appointed as Whole-Time Director.
Ceased
Ravi Devaki Venkataraman ceased to be Director.
Ceased
Srinivasan Ramani Harikesanallur ceased to be Director.
Incorporation
27 Apr 2015
Eywa Pharma Private Limited was registered on 27 Apr 2015 with Roc Chennai & aged 11 years 6 months as per MCA records.
Frequently asked questions
Eywa Pharma is an active private limited company based in Chengalpattu, Tamil Nadu, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 27 April 2015 (11+ years old) and is registered under CIN U74900TN2015PTC100269.
Eywa Pharma has 2 current directors:
- Sivakumar Jayaraman - Whole-Time Director
- Seshan Srinivasan - Director
The latest financial statements of Eywa Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2016 are in the company report.
The GSTIN of Eywa Pharma is 33AADCE9404E1Z0, registered in Tamil Nadu. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.
The CIN (Corporate Identification Number) of Eywa Pharma is U74900TN2015PTC100269. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Eywa Pharma was incorporated on 27 April 2015, making it 11+ years old. It is registered with the Registrar of Companies, Chennai.
Eywa Pharma has 2 deals on record (1 rights issue, 1 secondary share transfer); the latest was in November 2016.
Jayakumar Ramamoorthy ceased to be Managing Director on 30 Apr 2025. Seshan Srinivasan was appointed as Director on 30 Apr 2025. Subrata Ghosh ceased to be Whole-Time Director on 29 Feb 2024. Eywa Pharma has 7 board changes on record in total.
Yes, Eywa Pharma is registered as a small enterprise under Udyam registration (number: UDYAM-TN-02-0003922).
Eywa Pharma has 12 MSME Form 1 returns on record between 2019 and 2023, listing 706 overdue payments to 52 micro and small suppliers. The latest return was filed on 04 Nov 2023.
Eywa Pharma can be reached through the website eywapharma.sg. Its registered office is in Chengalpattu, Tamil Nadu, India.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages